Form D · Biotechnology
SIAMAB THERAPEUTICS, INC.
Newton, MA · CIK 0001351615
Offering snapshot reported Nov 8, 2018 · SEC filing
- Reported sold
- $665K Offering amount: $2M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 8, 2018 | Initial | $664,501 | No comparison | 21 | SEC filing |
| Mar 30, 2016 | Amendment | $3,213,332 | $1,213,156vs Apr 9, 2015 | 64 | SEC filing |
| Apr 9, 2015 | Initial | $2,000,176 | No comparison | 58 | SEC filing |
| Jul 10, 2014 | Initial | $526,998 | No comparison | 9 | SEC filing |
| Feb 27, 2014 | Amendment | $2,464,207 | $1,494,635vs Jul 30, 2013 | 43 | SEC filing |
| Jul 30, 2013 | Initial | $969,572 | No comparison | 24 | SEC filing |
| Oct 10, 2012 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Aug 17, 2011 | Initial | $875,000 | No comparison | 9 | SEC filing |
| Mar 22, 2010 | Initial | $700,000 | No comparison | 3 | SEC filing |
| Jan 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325402
Source: Form D, filed Nov 8, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Behrens | Director, Executive |
| Brad Curley | Director |
| Mark Hattendorf | Director, Executive |
| Peter Kroon | Director |
| Robert Mashal | Director |
| Gary Pforzheimer | Director |
| Sundar Subramaniam | Director |
| Nissi Varki | Director |
| Ajit Varki | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
90 Bridge Street, Suite 100
Newton, MA, 02458
Newton, MA, 02458